MGC Pharmaceuticals signs supply deal with AMC for phytomedicine products
MGC Pharmaceuticals, a developer of phytocannabinoid-derived medicines, has signed a $24 million supply and distribution deal with US-based AMC Holdings. The deal is for the ... Read More
MGC Pharma to acquire clinical and medical research firm MediCaNL
MGC Pharmaceuticals (MGC Pharma), a bio-pharma company focused on phytocannabinoid-derived medicines, has acquired MediCaNL, the owner of Israeli clinical and medical research company MediCaNL Israel ... Read More